NH Korindo Sekuritas Indonesia
Menu
  • Our Service
    • News & Research
      • News
      • Equity Report
      • Research Fixed Income
      • Company Report
      • Outlook
      • Special Notation
    • Equity
    • Fixed Income
    • Margin
    • Investment Banking
      • IPO
      • E-IPO
    • Wealth Management
      • Mutual Funds
    • Download Center
      • Download NAIK
      • Documents
    • Academy
      • Stock Dictionary
      • Stock Education
  • About Us
    • Our Firm
    • Our People
    • Our Branch
    • Corporate Governance
    • Careers
    • FAQ
  • Contact
  • Register Now
  • ID
  • EN

KLBF – Remains Conservative during Tough Period

  • Author
  • Recent Posts
Putu Chantika
Putu Chantika
Analyst - Consumer, Retail
Putu Chantika
Latest posts by Putu Chantika (see all)
  • ICBP – Supported by Topline Growth - December 20, 2021
  • ACES – Slowdown in 3Q21 Sales - December 7, 2021
  • ERAA – Continue on Growth Path - December 1, 2021

KLBF recorded modest top-line and bottom-line growth in 1Q20. This growth was supported by all segments which recorded excellent performance. On the margin side, GPM and OPM both recorded contractions which triggered by COGS. This is an opposite to the NPM which rise was ensured by a lower Opex and foreign currency gain. We project that KLBF will have to bear the challenge caused by the COVID-19 pandemic.
Nevertheless, at this point, we still maintain our estimates for FY20 at a conservative growth rate.

Download full report HERE.

Share This Article

Related Article


Company Report | [SIDO IJ] Continuing To Widen Bottom-Line Margin, Higher Overseas Revenue, And Expand Into Younger Consumer Bases

26 Mar 2025

FY24 Total Revenue achieved of 10% to IDR 3,919 bn. There was robust top-line growth across all revenue segments Herbal and Supplements with 6% YoY; Food and Beverages (18% YoY); and Pharmaceutical (10% YoY).

Company Report | [CUAN] Acquisitions Bear Fruit, New Mine Commences

26 Mar 2025

Petrindo Jaya Kreasi (CUAN) reported an impressive 718.6% YoY rise in revenue (USD 801.7 M vs USD 97.9 M) and 929.3% increase in net income (USD 160.8 M vs USD 15.6 M) for FY24.

Company Report | [SMSS IJ] Shifting Towards Diversified CPO Derivative Products

17 Mar 2025

On a quarterly basis, 3Q24 sales declined by 19% QoQ (vs 2Q24’s 10% QoQ) as the Sales are usually weakest on the first and third quarter. In the fourth quarter, sales consistently shot up by historical evidence in 4Q23 & 4Q22 with 303% QoQ & 85% QoQ, respectively.

 

More Article

Daily Report

09 May 2025

Daily Report | 9 May 2025

Stocks rose Thursday after President Donald Trump announced a trade deal framework betw...

READ MORE

Daily Report

27 Mar 2025

Daily Report | 27 March 2025

The S&P 500 lost 1.1%, while the Dow Jones Industrial Average traded 205 points lower, ...

READ MORE

Analysis Report

26 Mar 2025

Company Report | [SIDO IJ] Continuing To Widen ...

FY24 Total Revenue achieved of 10% to IDR 3,919 bn. There was robust top-line growth ac...

READ MORE

Contact Us

  • Treasury Tower 51th Floor, District 8, SCBD Lot 28, Jl. Jend. Sudirman No.Kav 52-53, RT.5/RW.3, Senayan, Kebayoran Baru, South Jakarta City, Jakarta 12190
  • cso@nhsec.co.id
  • +62 21 5088 9100 (Representative Number)
    +62 21 5088 9102 (CS Number)
  • +628 118 198 111 (Official Whatsapp 1)
    +6281 67 0000 5 (Official Whatsapp 2)

Link

  • Our Firm
  • Research
  • Our People
  • Download
  • Dictionary
  • FAQ

Certified By

Data yang ditampilkan di aplikasi PT NH Korindo Sekuritas Indonesia berasal dari BEI dan telah disetujui untuk ditampilkan.

PT NH Korindo Sekuritas Indonesia terdaftar dan diawasi oleh Otoritas Jasa Keuangan (OJK).


Copyright 2021 NH Korindo Sekuritas. All rights reserved.